UBS Maintains Neutral on Angi, Lowers Price Target to $5
UBS analyst Kunal Madhukar maintains Angi (NASDAQ:ANGI) with a Neutral and lowers the price target from $11 to $5.
Stocks · News reference
8-K filing — Angi Inc. (ANGI)
Filed: 2026-07-09 AccNo: 0001705110-26-000071 Size: 151 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Truist Securities Maintains Buy on Angi, Lowers Price Target to $10
Truist Securities analyst Youssef Squali maintains Angi (NASDAQ:ANGI) with a Buy and lowers the price target from $12 to $10.
Angi shares are trading lower after the company reported worse-than-expected Q2 financial results.
Angi Q2 EPS $(5.70) Misses $0.08 Estimate, Sales $248.000M Miss $251.536M Estimate
Angi (NASDAQ:ANGI) reported quarterly losses of $(5.70) per share which missed the analyst consensus estimate of $0.08 by 7225 percent. This is a 2578.26 percent decrease over earnings of $0.23 per share from the same